| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 20, 2000
Revised on November 20, 2003
Accepted on November 25, 2003
From the Department of Integrative Physiology (M.C.O., B.M.P., R.L.M.), Department of Molecular, Cellular, and Developmental Biology (B.L.S., L.A.L), University of Colorado, Boulder, Colo. The present address for M.C.O. is the Department of Neuroscience, Neurophysiology, University of Uppsala, Uppsala, Sweden; and B.M.P. is at the Department of Molecular Physiology and Biophysics, University of Vermont, College of Medicine, Burlington, Vt.
* To whom correspondence should be addressed. E-mail: rmoore{at}spot.colorado.edu.
Familial hypertrophic cardiomyopathy (FHC) is a human genetic disorder caused by mutations in sarcomeric proteins. It is generally characterized by cardiac hypertrophy, fibrosis, and myocyte disarray. A transgenic mouse model of FHC with mutations in the actin-binding domain of the
-myosin heavy chain (MyHC) gene displays many phenotypes similar to human FHC. At 4 months, male transgenic (TG) mice present with concentric cardiac hypertrophy that progresses to dilation with age. Accompanying this latter morphological change is systolic and diastolic dysfunction. Left ventricular (LV) myocytes from male TG and wild-type (WT) littermates at 5 and 12 months of age were isolated and used for morphological and functional studies. Myocytes from 5- and 12-month-old TG animals had shorter sarcomere lengths compared with WT. This sarcomere length difference was abolished in the presence of 2,3-butanedione monoxime, suggesting that the basal level of contractile element activation was increased in TG myocytes. Myocytes from 12-month-old TG mice were significantly longer than those from age-matched WT controls, and TG myocytes exhibited Z-band disorganization. When cells were paced at 0.5 Hz, TG myocyte relengthening and the fall in intracellular [Ca2+] were slowed when compared with cells from age-matched WT controls. Moreover, an increased amount of
-myosin heavy chain protein was found in hearts from TG compared with WT. Thus, myocytes from the
-MyHC TG mouse model display many morphological and functional abnormalities that may help explain the LV dysfunction seen in this TG mouse model of FHC.
This article has been cited by other articles:
![]() |
B. M. Palmer, Y. Wang, P. Teekakirikul, J. T. Hinson, D. Fatkin, S. Strouse, P. VanBuren, C. E. Seidman, J. G. Seidman, and D. W. Maughan Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1939 - H1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Kabaeva, M. Zhao, and D. E. Michele Blebbistatin extends culture life of adult mouse cardiac myocytes and allows efficient and stable transgene expression Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1667 - H1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Bondarenko and R. L. Rasmusson Simulations of propagated mouse ventricular action potentials: effects of molecular heterogeneity Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1816 - H1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Mueller, S. A. Grandy, and S. E. Howlett Protein Kinase A-Mediated Phosphorylation Contributes to Enhanced Contraction Observed in Mice That Overexpress beta-Adrenergic Receptor Kinase-1 J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1307 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Richard, E. Villard, P. Charron, and R. Isnard The Genetic Bases of Cardiomyopathies J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A79 - A89. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Izu, S. A. Means, J. N. Shadid, Y. Chen-Izu, and C. W. Balke Interplay of Ryanodine Receptor Distribution and Calcium Dynamics Biophys. J., July 1, 2006; 91(1): 95 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Konhilas, P. A. Watson, A. Maass, D. M. Boucek, T. Horn, B. L. Stauffer, S. W. Luckey, P. Rosenberg, and L. A. Leinwand Exercise Can Prevent and Reverse the Severity of Hypertrophic Cardiomyopathy Circ. Res., March 3, 2006; 98(4): 540 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Emter, S. A. McCune, G. C. Sparagna, M. J. Radin, and R. L. Moore Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2030 - H2038. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |